Urano T, Nagai N, Matsuura M, Ihara H, Takada Y, Takada A
Department of Physiology, Hamamatsu University, School of Medicine, Shizuoka, Japan.
Thromb Haemost. 1998 Jul;80(1):161-6.
Employing a fibrin clot lysis assay, we reassessed the significance of the neutralization of plasminogen activator inhibitor type 1 (PAI-1) activity by thrombin and factor-Xa in fibrinolysis. When PAI-1 enriched fibrin clots were formed using increasing concentrations of thrombin (0.1, 0.5, 1.0 IU/ml), their lysis times became shorter (43.8 +/- 4.9, 25.7 +/- 3.7, 13.9 +/- 0.8 h respectively). Times were shortened further by either heparin (43.9 +/- 11.0, 12.1 +/- 2.6, 3.6 +/- 0.2 h respectively) or vitronectin (17.0 +/- 1.6, 1.9 +/- 0.7, 0.9 +/- 0.0 h respectively). Factor-Xa together with Ca++ shortened the clot lysis time further. Fibrin autography revealed that both enzymes dose dependently interfered with complex formation between tPA and PAI-1, making large amounts of tPA remaining to be free form. The mechanism seems to play a role in the coagulation associated enhancement of fibrinolysis.
采用纤维蛋白凝块溶解试验,我们重新评估了凝血酶和因子Xa在纤维蛋白溶解过程中对1型纤溶酶原激活物抑制剂(PAI-1)活性的中和作用的重要性。当使用浓度不断增加的凝血酶(0.1、0.5、1.0 IU/ml)形成富含PAI-1的纤维蛋白凝块时,它们的溶解时间缩短(分别为43.8±4.9、25.7±3.7、13.9±0.8小时)。肝素(分别为43.9±11.0、12.1±2.6、3.6±0.2小时)或玻连蛋白(分别为17.0±1.6、1.9±0.7、0.9±0.0小时)可进一步缩短溶解时间。因子Xa与Ca++一起可进一步缩短凝块溶解时间。纤维蛋白自显影显示,这两种酶均剂量依赖性地干扰tPA与PAI-1之间的复合物形成,使得大量tPA保持游离形式。该机制似乎在凝血相关的纤维蛋白溶解增强中发挥作用。